Ashini Singh

About

Ashini Singh is an academician and researcher in Pharmacology with experience in teaching and research. She holds a B.Pharm from Dr. APJ Abdul Kalam Technical University, Lucknow and an M.Pharm in Pharmacology from Noida Institute of Engineering and Technology, Greater Noida. She is currently pursuing her Ph.D. in Pharmacology at GLA University, Mathura, with research focused on the neuroprotective potential of phytochemicals in neurodegenerative disorders using in vivo, in silico, and biochemical approaches. She has also worked on clinical aspects of diabetes management during her postgraduation. Ms. Singh has published her research in reputed journals. She is known for her vibrant personality, effective communication skills, and ability to connect with students and colleagues. With her dual role as a teacher and researcher, she is passionate about nurturing studentsgrowth through academic support and career-oriented guidance.

Experience

06+ Years

Qualification

M. Pharm (Pharmacology), PhD*

Award & Recognition

Publications in indexed journals; conference paper presentations (national & international).

Research

• Singh NK, Singh P, Varshney P, Singh A, Bhushan B. Multimodal action of phosphodiesterase 5 inhibitors against neurodegenerative disorders: An update review. J Biochem Mol Toxicol. 2024;38(11):e70021. doi:10.1002/jbt.70021
• Singh A, Sinha S, Singh NK. Dietary Natural Flavonoids: Intervention for MAO-B Against Parkinson's Disease. Chem Biol Drug Des. 2024;104(3):e14619.
• Singh NK, Singh A, Mayank. Nuclear Factor Kappa B: A Nobel Therapeutic Target of FlavonoidsAgainst Parkinson's Disease. Comb Chem High Throughput Screen. 2024;27(14):2062-2077. doi:10.2174/0113862073295568240105025006
• Singh A, Kumar Singh N. Pre-clinical Evidence-based Neuroprotective Potential of Naringin against Alzheimer's Disease-like Pathology: A Comprehensive Review. Curr Pharm Biotechnol. 2024;25(9):1112-1123. doi:10.2174/1389201024666230801095526
• Singh NK, Singh A, Varshney M, Agrawal R. A Research Update on Exendin-4 as a Novel Molecule against Parkinson's Disease. Curr Mol Med. 2023;23(9):889-900.
• Mazumder A, Singh A. A Review on Metformin: Clinical Significance and Side Effects. Res J Pharm Technol. 2021; 14(11):6179-6. doi: 10.52711/0974-360X.2021.01070
• Mazumder A, Singh A, Jha S. Study of side effects of metformin immediate release in comparison with sustained and extended release in type 2 diabetic patients of a tertiary care hospital in North India. Int J Pharm Res. 2021;13(2):1934-39. doi:
• 06 Paper presented in National and International Conferences

Certifications

• Certified and trained from the National Institute of Biologicals (Noida, U.P.) in animal handling and laboratory practices for pharmacological research.
• Certified and trained in pharmaceutical manufacturing operations and exposure to sales and marketing practices.
• Certified and trained in large-scale manufacturing and quality assurance of parenteral dosage forms.

Area of Interest

Research interests include neuropharmacology with emphasis on oxidative stress, mitochondrial dysfunction, and the role of natural compounds in neurological disorders. Also interested in clinical pharmacology, clinical surveillance, and evidence-based pharmacological practices that can further improve and adhere to current pharmacological trends.